Research Papers Published

• "DNA repair gene XRCC1 in relation to genome instability and role in colorectal carcinogenesis." Oncology research & Treatment., 37(78): 418 -422 {ISSN: 10.1159} Impact Factor= 1.5
• "High sensitivity hs-CRP levels and its relationship with PCOS in Indian Adolescent women with PCOS." Gynecological Endocrinology, 19(19): 1 -4 {ISSN: 12267} Impact Factor= 1.136
• "Polymorphism of the DNA Repair Gene XRCC1 (Arg194Trp) and its role in Colorectal Cancer in Kashmiri Population: a Case Control Study" Asian Pacific Journal of Cancer Prevention, 16(15): 6385 -6390 {ISSN: 10.7314} Impact Factor= 2.514
• "Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-a Levels in Women with Polycystic Ovary Syndrome: A Pilot Study." J Pediatr Adolesc Gynecol., 7(2): 1 -7 {ISSN: 1083-3188} Impact Factor= 1.683
• "The ICAM-1 Gly241Arg Polymorphism is Not Associated With Polycystic Ovary Syndrome - Results from a Case Control study in Kashmir, India." Asian Pac J Cancer Prev., 17(3): 1583 -1591 {ISSN: 1513-7368} Impact Factor= 2.514
• "Role of TLR4 gene polymorphisms in the colorectal cancer risk modulation in ethnic Kashmiri population – A case–control study" Egyptian Journal of Medical Human Genetics, 10(5): 1 -7 {ISSN: 1110-8630} Impact Factor= 0.404
• "Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-a Levels in Women with Polycystic Ovary Syndrome: A Pilot Study" J Paed Adol & Gynecology, 10(1): 58 -62 {ISSN: 1083-3188} Impact Factor= 1.9
• "The ICAM-1 Gly241Arg Polymorphism is Not Associated With Polycystic Ovary Syndrome - Results from a Case Control study in Kashmir, India." Asian Paci J of cancer prevention, 17(3): 153 -158 {ISSN: 1513-7368} Impact Factor= 2.6
• "Glutathione S Transferases: Biochemistry, Polymorphism and Role in Colorectal Carcinogenesis" Journal of Carcinogenesis & Mutagenesis, 8(2): 1 -9 {ISSN: 2157-2518} Impact Factor= 2.5
• "Evaluation of deletion polymorphisms of glutathione S-transferase genes and colorectal cancer risk in ethnic Kashmiri population: A case-control study" Indian J Cancer, 53(4): 524 -528 {ISSN: 1998-4774} Impact Factor= 0.497
• "Metabolic Derangements and Possible CVD Risk in PCOS Women Owing to Use of OCP’s as a Treatment Mode – Pros and Cons." Journal of Endocrinology, Diabetes & Obesity, 5(3): 1109 -1119 {ISSN: 2333-6692} Impact Factor= 0.3
• "Comparative analysis of the Clinical, biochemical and hormonal profile of obese versus lean kashmiri PCOS patients-A pilot study" International journal of Advances in Science Engineering and Technology., 5(2): 65 -70 {ISSN: 2321-9009} Impact Factor= 2.5
• "Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-a levels in Women with Polycystic Ovary Syndrome: A Pilot Study." J Pediatr Adolesc Gynecol, 30:58-62(1): 58 -62 {ISSN: 1083-3188} Impact Factor= 1.683
• "POLYCYSTIC OVARY SYNDROME (PCOS) AND RELATED DISEASES" PRECISION MEDICINE, 2(1): 23 -29 {ISSN: 2456-2254} Impact Factor= 0.1
• "OXIDATIVE STRESS BIOMARKERS IN POLYCYSTIC OVARY SYNDROME (PCOS)" PRECISION MEDICINE, 2(1): 30 -38 {ISSN: 2456-2254} Impact Factor= 0.1
• "Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: An observational pilot study" IJMR, 2019(148): 151 -155 {ISSN: IP: 125.19} Impact Factor= 1.59
• "Effect of Paraoxonase1 (PON1) gene polymorphisms on PON1 activity, HDL, LDL and MDA levels in women with polycystic ovary syndrome (PCOS): A case-control study" META GENE, 2019(20): 100052 -100053 {ISSN: 2214-5400} Impact Factor= 0.89
• "Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study." Diabetes & Metabolic Syndrome: Clinical Research & Reviews., 2019(13): 1957 -61 {ISSN: 1871-4021} Impact Factor= 0.84
• "Evaluation of prescription pattern and compliance in Kashmiri women with Polycystic Ovarian Syndrome." Journal of Drug Delivery and Therapeutics., 2019(9(3)): 379 -383 Impact Factor=
• "Bisphenol A (BPA) acts as an endocrine disruptor in women with Polycystic Ovary Syndrome: Hormonal and metabolic evaluation." Obesity Medicine, 2019(14): 2451 -2476 Impact Factor=
• "Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome" Diabetes & metabolic syndrome: Clinical Research & Reviews, 2019(13(3)): 2098 -2105 Impact Factor=
• "Insulin gene VNTR class III allele is a risk factor for insulin resistance in Kashmiri women with polycystic ovary syndrome" Meta Gene., 2019(100597): 100597 -100606 Impact Factor=
• "Assessment of PON1 activity and circulating TF levels in relation to BMI, testosterone, HOMA-IR, HDL-C, LDL-C, CHO, SOD activity and TAC in women with PCOS: An observational study." Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019(12): 1871 -1878 Impact Factor=
• "Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study" Scientific reports, 2019(9): 10182 -10187 Impact Factor=
• "CYP 17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome." Gynecological Endocrinology, 2(2): 1 -6 {ISSN: 0951-3590} Impact Factor= 2.1
• "AT-rich Interaction domain 1A Gene variations: Genetic associations and susceptibility to gastric cancer." Pathology and oncology Research, 2(2): 1 -6 {ISSN: 1532-2807} Impact Factor= 2.8
• "Analysis of Intrinsic and Extrinsic Coagulation Pathway Factors in OCP Treated PCOS Women." Indian j Clinical Biochemistry, 1(2): 1 -12 {ISSN: 0974-04 22} Impact Factor= 1.4
• "Association of Paraoxonase1 enzyme and its genetic single nucleotide polymorphisms with cardio-metabolic and neurodegenerative diseases." Gene Reports, 1(2): 1 -9 {ISSN: 2452-01 44} Impact Factor= 0.9
• "Endocrine disrupting chemical Bisphenol A and its potential effects on female health." Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 1(2): 1 -10 {ISSN: 11} Impact Factor= 1.8
• "HIGH PREVALENCE OF METABOLIC SYNDROME IN KASHMIR (INDIA) ADULT POPULATION: TIME TO INTERVENE." Archives of Medicine and Health Sciences, 5(4): 1 -8 {ISSN: 2141-9248} Impact Factor= 0.9
• "Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer." Pathology and Oncology Research, 27(1): 1609826 -1609830 {ISSN: 1219-4956} Impact Factor= 3.201
• "Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study." Journal of Family Medicine and Primary Care | Published by Wolters Kluwer - Medknow, 11(2022;11:): 4743 -4752 {ISSN: 2249-4863} Impact Factor= 0.62
• "Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-a (TNF-a), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1(PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women." BMC WOMEN;S HEALTH, 23(23): 68 -75 {ISSN: 1472-6874} Impact Factor= 3.25
• "Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-a (TNF-a), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1(PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women." BMC WOMENS HEALTH, 63(28): 1 -15 {ISSN: 1472-6874} Impact Factor= 3.1
• "Mathematical analysis and empirical validation of Thermal denaturation of Glucokinase" Journal of Mechanics in Medicine and Biology, 2(1): Pub Med ID. 34 {ISSN: 1793-6810} Impact Factor= 0.8

Books Published

• "Proteostasis and Chaperone Surveillance/ Protein Misfolding diseases: In perspective of Gain and Loss of function". Springer , India. {ISBN: 978-81-322-2466-2} pp 14
• "Microbes in Reproductive tract spectrum: Inferences from microbial world. ( Pathogenicity and drug resistance of Human pathogens).". Springer International. {ISBN: 978-981-329-449-3} pp 14
• "An Overview of Possible Health Risk and Complications of Polycistic Ovary Syndrome.". Categories: 2021, Books, Endocrinology, Endocrinology Research and Clinical Developments, Medicine & Health, Medicine and Health, Newly Published Books, Nova Medicine and Health. {ISBN: ISBN: 978-1-53619-527-9} pp 179
• "Polycystic Ovary Syndrome: A Fresh Insight in Relation to Its Inflammatory and Coagulatory Pathophysiology.". Categories: 2021, Books, Endocrinology, Endocrinology Research and Clinical Developments, Medicine & Health, Medicine and Health, Newly Published Books, Nova Medicine and Health. {ISBN: ISBN: 978-1-53619-527-9} pp 179
• "Tissue Factor and Human Pathologies: A Comprehensive Insight.". Advances in Health and Disease. Volume 50. Nova Medicine and Health. {ISBN: 978-1-68507-564-4} pp 25
• "TISSUE FACTOR AND HUMAN PATHOLOGIES: A COMPREHENSIVE INSIGHT/ Avances in Health and Disease Humira Jeelani1, Muzamil Farooq2, Fasil Ali3, and Fouzia Rashid1,". Nova Publishers USA. {ISBN: TISSUE FACTOR AND HUMAN PATHO} pp 30
• "8. Thrombophilia and Its Markers: A Comprehensive Insight". SPRINGER. {ISBN: 978-981-99-2192-8} pp 15
• "9. Polycystic Ovary Syndrome (PCOS): Clinical Features, Risk Factors, Biomarkers, Treatment, and Therapeutic Strategies". SPRINGER. {ISBN: 978-981-99-2192-8} pp 16